Pancreatic Cancer: T-Cell Therapy – Phase 1/2 Trial
Promising New T Cell Therapy Shows Benefit in Pancreatic Cancer Trial In a significant development for patients battling pancreatic ductal adenocarcinoma, early results from the TACTOPS trial demonstrate the feasibility and safety of a novel autologous T cell therapy. The treatment, designed to target specific cancer-associated antigens, has yielded encouraging clinical responses and evidence of … Read more